Ocumetics Director and CEO, Dean Burns, walks through relevant topics including:
- Successful manufacture of the Ocumetics IOL
- Remaining steps to first-in-human study
- Q&A session
Thanks to everyone who joined us for the Webinar. It was an amazing turnout, and it was great to hear your questions and comments. We look forward to hosting more webinars in the future!
https://youtu.be/U0GrNVtLNSc?si=lZYKlYUM2tH-KDjJ
Tired of glasses? New lens technologies might offer a better way to see and experience the world. Anyone who relies on corrective eyewear has experienced its drawbacks. Maybe you are approaching your 50’s and need glasses to see up close. Maybe you left your reading glasses at home and find yourself asking for help deciphering
Ocumetics believes its accommodating lens technology could transform the eye care industry. Dr. Garth Webb, Ocumetics’ Founder and Chief Scientific Officer, thinks nothing is as beautiful as the lens in the human eye. “It’s this gorgeous, crystal-like orb that hides just behind the pupil,” he says. But it doesn’t stay that way forever. Inevitably, as
Many of the questions we receive from investors relate to the process for obtaining US Food and Drug Administration (FDA) approval for surgical devices, such as the Ocumetics Accommodating Lens. This month’s message is focused on outlining how the process works and unpacking the steps required to obtain FDA approval. You will be thrilled to
Imagine a world in which glasses and traditional contact lenses become obsolete, and natural vision is restored with a simple and innovative solution.
That's precisely what we aim to achieve with the Ocumetics Accommodating Lens technology (“Ocumetics Accommodating Lens”).
